Vytorin Fails To Show ENHANCEd Benefit Over Simvastatin In Plaque Reduction

Merck/Schering-Plough felt pressure to release findings earlier than its scheduled presentation at March American College of Cardiology meeting, Schering-Plough tells “The Pink Sheet” DAILY.